Differences by Resistotyping Between C. albicans Strains Isolated from the Oral Cavity of HIV+ and Seronegative Patients

Florencio Rueda-Gordillo; Sandra Elena Hernández-Solís; Luis Alberto Gaitán-Cepeda; Luis Octavio Sánchez-Vargas; Esperanza Mercedes Lama-González; María del Sagrado Corazón Rodríguez-Fernández

2018, Number 2

<< Back Next >>

Odovtos-Int J Dent Sc 2018; 20 (2)

**Differences by Resistotyping Between C. albicans Strains Isolated from the Oral Cavity of HIV+ and Seronegative Patients**

Rueda-Gordillo F, Hernández-Solís SE, Gaitán-Cepeda LA, Sánchez-Vargas LO, Lama-González EM, Rodríguez-Fernández MSC

Full text

How to cite this article

Language: English
References: 34
Page: 103-111
PDF size: 168.71 Kb.

ABSTRACT

Candida albicans is the etiological agent most frequently associated with oral candidiasis in human immunodeficiency virus (HIV) carriers. Strain typification is important to disease epidemiology, particularly with simple, low-cost methodologies such as resistotyping. The present study was designed to use resistotyping to identify possible phenotypic differences between C. albicans strains isolated from the oral cavity of HIV+ and HIV-seronegative patients. Analyses were run using resistotyping (boric acid, cetrimide, sodium periodate, sodium selenite and silver nitrate) to identify phenotypical differences between C. albicans. Descriptive statistics was performed. Of the 149 clones isolated from HIV+ patients the most frequent (47.0%) resistotype was ABCDE. The most frequent resistotype (64.8%) in the 74 clones from HIV-seronegative patients was --CDE. Phenotypic differences were identified between the strains isolated from each group. HIV+ patients exhibited greater strain diversity. Although it has limitations, resistotyping effectively identified differences between C. albicans strains.

REFERENCES

Egusa H., Soysa N. S., Ellepola A. N., Yatani H., Samaranayake L. P. Oral candidosis in HIVinfected patients. Curr HIV Res. 2008; 6 (6): 485-99. doi: 10.2174/157016208786501445. [PubMed: 18991614]
Askinyte D., Matulionyte R., Rimkevicius A. Oral manifestations of HIV disease: A review. Stomatologija. 2015; 17 (1): 21-8. [PubMed: 26183854].
Gaitán-Cepeda L. A., Martínez-González M., Ceballos-Salobreña A. Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART. AIDS Patient Care STDS. 2005; 19 (2):70-7. doi: 10.1089/ apc.2005.19.70. [PubMed: 15716638]
Taiwo O. O., Hassan Z. The impact of highly active antiretroviral therapy (HAART) on the clinical features of HIV - related oral lesions in Nigeria. AIDS Res Ther. 2010;7:19. doi: 10.1186/1742-6405-7-19. [PubMed: 20579347]
Gaitán-Cepeda L. A., Sánchez-Vargas O., Castillo N. Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis. Int J STD AIDS. 2015; 26 (9): 625-32. doi: 10.1177/0956462414548906. [PubMed: 25156369]
Hernández-Solís S. E., Rueda-Gordillo F., Flota-Alcocer A. D., Aguilar-Ayala F. J., Rodríguez-Fernández M. del S., Lama- González EM. Influence of orthodontic appliances on the occurrence of Candida spp. in the oral cavity. Rev Chilena Infectol. 2016; 33 (3): 293-7. doi: 10.4067/S0716- 10182016000300007. [PubMed: 27598278]
Mayer F. L., Wilson D., Hube B. Candida albicans pathogenicity mechanisms. Virulence. 2013; 4 (2): 119-28. doi: 10.4161/viru.22913
Vazquez J. A. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl). 2010; 2: 89-101. doi: 10.2147/HIV.S6660
Thewes S., Moran G. P., Magee B. B., Schaller M., Sullivan D. J., Hube B. Phenotypic screening, transcriptional profiling, and comparative genomic analysis of an invasive and non-invasive strain of Candida albicans. BMC Microbiol. 2008; 8: 187. doi: 10.1186/1471-2180-8-187. [PubMed: 18950481]
Choo K. H., Lee H. J., Knight N. J., Holmes A. R., Cannon R. D. Multilocus sequence typing (MLST) analysis of Candida albicans isolates colonizing acrylic dentures before and after denture replacement. Med Mycol. 2017; 55 (6): 673-9. doi: 10.1093/mmy/ myw128. [PubMed: 27915298]
Hernández-Solís S. E., Rueda-Gordillo F., Rojas-Herrera R. A. Proteinase activity in Candida albicans strains isolated from the oral cavity of immunocompromised patients, with oral candidiasis and in healthy subjects. Rev Iberoam Micol. 2014; 31 (2): 137-40. doi: 10.1016/j.riam.2013.09.003. [PubMed: 24071641]
Bitar I., Khalaf R. A., Harastani H., Tokajian S. Identification, typing, antifungal resistance profile, and biofilm formation of Candida albicans isolates from Lebanese hospital patients. Biomed Res Int. 2014; 2014: 931372. doi: 10.1155/2014/931372. [PubMed: 24982915]
Arce-Gil Z. L., Silva V., Silva V. Especies de Candida aisladas de muestra vaginal y orina de pacientes oncológicos del Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima, Perú. Genotipificación de Candida albicans. Rev Cuerpo Med HNAAA. 2015; 8 (3): 168-73.
González H., Da Silva I., Reyes E. Caracterización molecular de cepas de Candida albicans aisladas de candidiasis oral en personas VIH positivo. Cienc Trab. 2006; 8 (22): 172-6.
De Baere T., Claeys G., Swinne D., Verschraegen G., Muylaert A., Massonet C., et al. Identification of cultured isolates of clinically important yeast species using fluorescent fragment length analysis of the amplified internally transcribed rRNA spacer 2 region (ITS2). BMC Microbiol. 2002;2:21. doi: 10.1186/1471-2180-2-21. [PubMed: 12139769]
Yang C. W., Barkham T. M., Chan F. Y., Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol. 2003; 41 (1): 472-4. doi: 10.1128/JCM.41.1.472-474.2003. [PubMed: 12517898]
Nakamura K., Ito-Kuwa S., Nakamura Y., Aoki S., Vidotto V., Sinicco A. Resistogram typing of oral Candida albicans isolates from normal subjects in three successive trials. Rev Iberoam Micol. 1998; 15 (1): 19-21. [PubMed: 17655398].
Khan Z. U., Chandy R., Metwali K. E. Candida albicans strain carriage in patients and nursing staff of an intensive care unit: A study of morphotypes and resistotypes. Mycoses. 2003; 46 (11-12): 479-86. doi: 10.1046/j.0933-7407.2003.00929.x. [PubMed: 14641621]
Giammanco G. M., Lopes M. M., Coimbra R. S., et al. Value of morphotyping for the characterization of Candida albicans clinical isolates. Mem Inst Oswaldo Cruz. 2005; 100 (5): 483-90. doi: /S0074- 02762005000500007. [PubMed: 16184225]
Bruatto M., Vidotto V., Marinuzzi G., Raiteri R., Sinicco A. Candida albicans biotypes in human immunodeficiency virus type 1-infected patients with oral candidiasis before and after antifungal therapy. J Clin Microbiol. 1991; 29 (4): 726-30. [PubMed: 1679764].
Figueiral M. H., Fonseca P., Lopes M. M., Pinto E., Pereira-Leite T., Sampaio-Maia B. Effect of denture-related stomatitis fluconazole treatment on oral Candida albicans susceptibility profile and genotypic variability. Open Dent J. 2015; 9: 46-51. doi: 10.2174/1874210601509010046. [PubMed: 25674171]
Sampaio P., Gusmao L., Correia A., Alves C., Rodrigues A. G., Pina-Vaz C., et al. New microsatellite multiplex PCR for Candida albicans strain typing reveals microevolutionary changes. J Clin Microbiol. 2005; 43 (8): 3869-76. doi: 10.1128/JCM.43.8.3869-3876.2005. [PubMed: 16081924]
Hunter P. R., Fraser C. Use of modified resistogram to type Candida albicans isolated from cases of vaginitis and from faeces in the same geographical area. J Clin Pathol. 1987; 40 (10): 1159-61. doi: 10.1136/jcp.40.10.1159. [PubMed: 3316288]
McCreight M. C., Warnock D. W., Watkinson AC. Prevalence of different strains of Candida albicans in patients with dentureinduced stomatitis. Sabouraudia. 1984; 22 (1): 83-85. doi: 10.1080/00362178485380131. [PubMed: 6367101]
Menezes R. de P., Borges A. S., Araujo L. B., Pedroso Rdos S., Roder D. V. Related factors for colonization by Candida species in the oral cavity of HIV-infected individuals. Rev Inst Med Trop Sao Paulo. 2015; 57 (5): 413- 9. doi: 10.1590/S0036-46652015000500008. [PubMed: 26603229]
Pongsiriwet S., Iamaroon A., Sriburee P., Pattanaporn K., Krisanaprakornkit S. Oral colonization of Candida species in perinatally HIV-infected children in northern Thailand. J Oral Sci. 2004; 46 (2): 101-5. doi: 10.2334/ josnusd.46.101. [PubMed: 15287543]
Hadrich I., Ranque S. Typing of fungi in an outbreak setting: Lessons learned. Curr Fungal Infect Rep. 2015; 9 (4): 314-23. doi: 10.1007/s12281-015-0245-y
Nyazika T. K., Robertson V. J., Nherera B., Mapondera P. T., Meis J. F., Hagen F. Comparison of biotyping methods as alternative identification tools to molecular typing of pathogenic Cryptococcus species in sub-Saharan Africa. Mycoses. 2016; 59 (3): 151-6. doi: 10.1111/myc.12444. [PubMed: 26661484]
Gil-Lamaignere C., Roilides E., Hacker J., Muller F. M. Molecular typing for fungi--a critical review of the possibilities and limitations of currently and future methods. Clin Microbiol Infect. 2003; 9 (3): 172-85. doi: 10.1046/j.1469- 0691.2003.00649.x. [PubMed: 12667249]
Saghrouni F., Ben Abdeljelil J., Boukadida J., Ben Said M. Molecular methods for strain typing of Candida albicans: A review. J Appl Microbiol. 2013; 114 (6): 1559-74. doi: 10.1111/jam.12132. [PubMed: 23311504]
Otero L., Vázquez F., Palacio V., Vázquez S., Carreño F., Méndez F. J. Comparison of seven phenotyping methods for Candida albicans. Eur J Epidemiol. 1995; 11 (2): 221-4. doi: 10.1007/BF01719492. [PubMed: 7672080]
O'Connell B., Coleman D. C., Bennett D., Sullivan D., McCann S. R., Keane C. T. An epidemiological study of Candida species infection in cancer patients using genetic fingerprinting and morphotyping. J Hosp Infect. 1995; 31 (3): 211-7. doi: 10.1016/0195- 6701(95)90068-3. [PubMed: 8586790]
Buzzini P., Turchetti B., Vaughan-Martini A. E. The use of killer sensitivity patterns for biotyping yeast strains: The state of the art, potentialities and limitations. FEMS Yeast Res. 2007; 7 (6): 749-60. doi: 10.1111/j.1567- 1364.2007.00238.x. [PubMed: 17425671]
Prasobh K. K., Udhaya V., Sarayu Y. L. Resistotyping of Candida albicans isolated from sputum samples of patients attending TB clinics in and around Chidambaram. Rec Res Sci Tech. 2009; 1 (4): 180-3.